Molecular Characteristics
Complete Specifications
Structural Composition
Synthetic small-molecule structure designed for modulation of metabolic signaling pathways (exact structure not publicly disclosed)
Physical Properties
SLU-PP-322 is a synthetic small-molecule compound under investigation for its interaction with metabolic regulatory pathways. As a non-peptide compound, it is not subject to proteolytic degradation. Stability characteristics depend on formulation and storage conditions; protection from moisture, light exposure, and elevated temperatures is recommended to maintain compound integrity. Storage in a dry, controlled environment helps preserve analytical consistency for research applications.
Research Applications
Nuclear Receptor Signaling Research
SLU-PP-322 is utilized as a small-molecule agonist in research studies examining estrogen-related receptor (ERR) signaling and transcriptional regulatory pathways associated with cellular energy metabolism. Laboratory investigations focus on its role in:
- ERRα/ERRγ Activation Models: Investigation of receptor binding dynamics and transcriptional coactivator recruitment
- PGC-1α Interaction Studies: Evaluation of coactivator-mediated gene expression linked to mitochondrial function
- Transcriptional Regulation Research: Analysis of nuclear receptor–driven metabolic gene expression programs
- Ligand Selectivity Models: Examination of receptor specificity and activation profiles across nuclear receptor subtypes
- Compound Stability Studies: Investigation of structural persistence and activity duration in experimental systems
Experimental protocols commonly employ receptor-binding assays, reporter gene systems, and transcriptional profiling techniques to characterize SLU-PP-322–mediated signaling responses.
Mitochondrial Biogenesis and Energy Metabolism Research
SLU-PP-322 has been examined in research contexts involving mitochondrial regulation and cellular energy metabolism pathways. Key areas of investigation include:
- Mitochondrial Biogenesis Models: Evaluation of transcriptional pathways associated with organelle replication and function
- Oxidative Phosphorylation Studies: Investigation of signaling cascades influencing ATP production efficiency
- Fatty Acid Oxidation Research: Analysis of metabolic pathways regulating substrate utilization
- AMPK Interaction Models: Research into coordinated signaling between nuclear receptors and energy-sensing pathways
- Metabolic Adaptation Studies: Examination of cellular responses to increased energy demand conditions
These studies utilize metabolic flux assays, mitochondrial respiration measurements, and gene expression analyses to evaluate energy-regulatory outcomes.
Skeletal Muscle and Endurance Signaling Research
SLU-PP-322 has also been explored in research models examining skeletal muscle signaling and endurance-associated intracellular pathways, including:
- Myocyte Signaling Studies: Evaluation of intracellular cascades associated with muscle energy metabolism
- Fiber Type Regulation Models: Investigation of transcriptional pathways influencing oxidative muscle phenotype
- Mitochondrial Density Research: Analysis of intracellular mechanisms affecting energy capacity within muscle cells
- Lactate Utilization Studies: Examination of metabolic signaling associated with endurance adaptation
Laboratory protocols assess muscle cell markers, transcriptional activity, and intracellular signaling cascades using biochemical and molecular techniques.
Cellular Signaling and Metabolic Network Research
Additional research applications explore SLU-PP-322’s influence on intracellular regulatory systems involved in metabolic coordination and energy homeostasis, including:
- MAPK and PI3K-AKT Pathway Studies: Investigation of cascades associated with cellular adaptation and survival signaling
- Gene Expression Profiling: Analysis of transcriptional responses linked to metabolic regulatory systems
- Receptor Modulation Research: Examination of adaptive signaling modulation within nuclear receptor systems
- Integrated Bioenergetic Network Models: Analysis of coordinated signaling systems maintaining cellular energy equilibrium
Research in this domain focuses on understanding how SLU-PP-322 influences nuclear receptor–mediated signaling pathways, mitochondrial regulation, and adaptive metabolic responses under controlled experimental conditions.
Laboratory Handling and Storage Protocols
Lyophilized Powder Storage
- Store at –20°C to –80°C in the original, sealed vial
- Protect from light exposure and moisture
- A desiccated storage environment is recommended
- Stability data suggests extended stability when stored at −20 °C or below.
Reconstituted Solution Storage
- Short-term storage: Up to 7 days at 4°C
- Long-term storage: Store at –20°C in aliquots
- Use single-use aliquots to preserve peptide integrity
- Minimize freeze–thaw cycles; single-use aliquots are strongly recommended
Stability Characteristics
Selank is a synthetic peptide research compound that demonstrates stable handling characteristics when managed according to standard peptide laboratory protocols. Proper cold storage of the lyophilized material, careful reconstitution, and minimized freeze–thaw exposure help maintain structural integrity and solubility. When handled appropriately, Selank supports consistent use in in vitro and analytical research applications.
Frequently Asked Questions
What is SLU-PP-322?
SLU-PP-322 is a synthetic research compound investigated for its role in metabolic signaling and transcriptional regulation pathways, often in models related to energy balance and cellular metabolism.
What is SLU-PP-322 commonly researched for?
In laboratory and preclinical models, SLU-PP-322 is studied for:
- Nuclear receptor pathway investigations
- Metabolic regulation and energy utilization research
- Skeletal muscle gene expression models
- Mitochondrial and oxidative metabolism studies
- Transcriptional activation pathway analysis
All applications are exploratory and conducted in controlled research environments.
Is SLU-PP-322 a peptide?
No. SLU-PP-322 is a small-molecule compound, not a peptide, and is structurally distinct from peptide-based research compounds.
How does SLU-PP-322 differ from compounds like AICAR or GW-related compounds?
SLU-PP-322 is studied for its own distinct nuclear receptor and metabolic signaling interactions, whereas other compounds may target different pathways or receptor systems. These differences are evaluated in experimental models.
How is SLU-PP-322 supplied?
SLU-PP-322 is typically supplied as a powder or crystalline compound in sealed containers suitable for laboratory handling and storage.
How should SLU-PP-322 be stored?
SLU-PP-322 should be stored:
- At room temperature or 2–8 °C, depending on manufacturer guidance
- In a sealed container
- Protected from light, heat, and moisture
How should prepared solutions be handled and stored?
Once dissolved:
- Store at 2–8 °C for short-term laboratory use
- Prepare fresh solutions when possible
- Minimize prolonged exposure to light and air
- Follow solvent-specific stability guidelines
Does SLU-PP-322 require a Certificate of Analysis (COA)?
Yes. A Certificate of Analysis (COA) should be available for each batch, verifying peptide identity, purity, and analytical testing results to ensure research quality and traceability.
Is SLU-PP-322 FDA-approved?
No. SLU-PP-322 is not FDA-approved as a drug, supplement, or therapeutic product. It is sold exclusively as a research compound and must not be marketed or used for diagnostic, therapeutic, or consumption purposes.
This product is not for human consumption. It is sold strictly for research and educational purposes and is not intended to diagnose, treat, cure, or prevent any disease.
Any clinical data or research information referenced on this page is derived from peer-reviewed scientific literature and official publications. This information is provided for educational reference only and does not constitute medical advice or product claims.
By purchasing this product, you acknowledge that you are a qualified researcher and agree to use it in full compliance with all applicable laws and regulations.
